Ubiquitin-proteasome system (UPS) as a target for anticancer treatment

被引：242

作者：

Park, Jinyoung ^{[1
]}

Cho, Jinhong ^{[2
]}

Song, Eun Joo ^{[2
]}

机构：

[1] Korea Inst Sci & Technol, Mol Recognit Res Ctr, Hwarangno 14 Gil 5, Seoul 02792, South Korea

[2] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, 52 Ewhayeodae Gil, Seoul 03760, South Korea

来源：

ARCHIVES OF PHARMACAL RESEARCH | 2020年 / 43卷 / 11期

基金：

新加坡国家研究基金会;

关键词：

Ubiquitin– proteasome system (UPS); E3; ligase; Deubiquitinating enzymes (DUBs); Proteasome; Cancer; Small molecule inhibitors; MULTIPLE-MYELOMA CELLS; CANCER THERAPEUTIC TARGET; SMALL-MOLECULE INHIBITOR; TUMOR-SUPPRESSOR CYLD; FATTY-ACID SYNTHASE; NF-KAPPA-B; BREAST-CANCER; IN-VIVO; PROMOTES PROLIFERATION; CYCLIN-E;

D O I：

10.1007/s12272-020-01281-8

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The ubiquitin-proteasome system (UPS) plays an important role in the cellular processes for protein quality control and homeostasis. Dysregulation of the UPS has been implicated in numerous diseases, including cancer. Indeed, components of UPS are frequently mutated or abnormally expressed in various cancers. Since Bortezomib, a proteasome inhibitor, received FDA approval for the treatment of multiple myeloma and mantle cell lymphoma, increasing numbers of researchers have been seeking drugs targeting the UPS as a cancer therapeutic strategy. Here, we introduce the essential component of UPS, including ubiquitinating enzymes, deubiquitinating enzymes and 26S proteasome, and we summarize their targets and mechanisms that are crucial for tumorigenesis. In addition, we briefly discuss some UPS inhibitors, which are currently in clinical trials as cancer therapeutics.

引用

页码：1144 / 1161

页数：18

共 50 条

[1] Ubiquitin–proteasome system (UPS) as a target for anticancer treatment
Jinyoung Park
Jinhong Cho
Eun Joo Song
Archives of Pharmacal Research, 2020, 43 : 1144 - 1161
[2] Ubiquitin-proteasome system as a target for anticancer treatment-an update
Kim, Yeon Jung
Lee, Yeonjoo
Shin, Hyungkyung
Hwang, SuA
Park, Jinyoung
Song, Eun Joo
ARCHIVES OF PHARMACAL RESEARCH, 2023, 46 (07) : 573 - 597
[3] Ubiquitin–proteasome system as a target for anticancer treatment—an update
Yeon Jung Kim
Yeonjoo Lee
Hyungkyung Shin
SuA Hwang
Jinyoung Park
Eun Joo Song
Archives of Pharmacal Research, 2023, 46 : 573 - 597
[4] The Ubiquitin-Proteasome System (UPS) and Viral Infection in Plants
Lobaina, Dania P.
Tarazi, Roberto
Castorino, Tamara
Vaslin, Maite F. S.
PLANTS-BASEL, 2022, 11 (19):
[5] Targeting Ubiquitin-Proteasome system (UPS) in treating osteoarthritis
Wong, Pooi-Fong
Kamarul, Tunku
EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 989
[6] The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib
Cvek, Boris
Dvorak, Zdenek
CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (15) : 1483 - 1499
[7] The Role of Ubiquitin-Proteasome System (UPS) in Asthma Pathology
Deng, Shuzhou
Ding, Le
Qian, Yisong
Huang, Xuan
JOURNAL OF ASTHMA AND ALLERGY, 2025, 18 : 307 - 330
[8] Safety first: The ubiquitin-proteasome system (UPS) and photosynthesis
Grimmer J.
Baginsky S.
BIOspektrum, 2021, 27 (4) : 394 - 397
[9] Drug Development Targeting the Ubiquitin-Proteasome System (UPS) for the Treatment of Human Cancers
Zhang, Xiaonan
Linder, Stig
Bazzaro, Martina
CANCERS, 2020, 12 (04)
[10] The Ubiquitin-Proteasome System as a Prospective Molecular Target for Cancer Treatment and Prevention
Chen, Di
Dou, Q. Ping
CURRENT PROTEIN & PEPTIDE SCIENCE, 2010, 11 (06) : 459 - 470

← 1 2 3 4 5 →